Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence. The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care. Focused on the oncology space, Realyze Intelligence rapidly analyzes structured and unstructured data in electronic health records (EHRs) to identify ideal patients for clinical trials and other research studies. Realyze Intelligence’s clinician-trained AI can assemble appropriate cohorts in seconds instead of the typical hours or days the process consumes when performed manually.
Read the full article: Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company //
Source: https://www.prnewswire.com/news-releases/carta-healthcare-to-power-oncology-research-and-clinical-trials-with-acquisition-of-realyze-intelligence-a-upmc-enterprises-company-302325384.html